Posts by B-BIC

TIPS AND TRICKS: Defining Your Competitive Landscape

The first step in defining your competitive landscape is to identify and define the technology’s current competition and how they fit into or define current standard of care (SoC). An important step in the process is to forecast how is the SoC landscape may shift during your technology/product development. Identify other technologies/products in development that…

Read More

Specialist Series: Defining Your Competitive Landscape

Contributed by John Randle, Phd B-BIC COACH PRINCIPAL, RANDOM WALK VENTURES, LLC COO, KANTUM BIO The first step in defining your competitive landscape is to identify and define the technology’s current competition and how they fit into or define current standard of care (SoC).  List the products or substitutes that you would aim to replace…

Read More

NEW AWARD: CONGRATULATIONS DR J. BRIAN MCALVIN

RECIPIENT:  Dr. J. Brian McAlvin TITLE: A Novel Method To Treat The Systemic Inflammatory Response Syndrome (SIRS) TYPE OF AWARD: Pilot TECHNOLOGY TYPE: Therapeutic Device CLINICAL AREA: Blood INSTITUTION: Boston Children’s Hospital DESCRIPTION: We have developed highly-selective blood-filtering devices that are capable of filtering of individual, harmful molecules from the blood of patients rendered critically ill by the…

Read More

EVENT: FAST PITCH FOR FUNDING

ARE YOU THINKING ABOUT COMMERCIALIZING YOUR RESEARCH? Fast Pitch for Funding is an event hosted by the Boston Biomedical Innovation Center, that provides you the opportunity to pitch a team of experts on your research. You will receive immediate feedback with the opportunity to apply for our grant programs which can provide up to $350,000…

Read More

Tufts University Joins Boston Biomedical Innovation Center With Goal of Advancing Health by Speeding New Technologies to Market

B-BIC’s expanding network signals the importance of forming partnerships in effort to commercialize biomedical technologies and improve healthcare. January 2018 – The Boston Biomedical Innovation Center (B-BIC), a National Center for Accelerated Innovation designed to stimulate the commercialization of biomedical technologies, today announced that Tufts University will join B-BIC as an Associate Core Member. Tufts…

Read More

Tips & Tricks: Explaining Your Proposed Solution

Understand the population you are targeting and why.  It may be preferable to define a narrower niche for your entry to the market. Consider where your device/drug will be administered and by what means.  This choice will greatly influence the preclinical and clinical development needs and strategies. Most investors will want to see proof-of-concept (POC)…

Read More

Specialist Series: Filling the Unmet Need – Your Proposed Solution

Contributed by Ron Blackman In our previous newsletter, we described how to identify the unmet need that will be served by your device or therapeutic, and here we will help you build the case that you have a solution to meet that need.  A number of points should be addressed and we will go through…

Read More

Tips & Tricks: Defining Your Need Statement

Contributed by Josh Tolkoff An unmet need is more than an incremental improvement and once it exists in the market – it makes a substantial change for the better. Talk with many stakeholders (patients, clinicians, hospital administrators, hospital purchasing agents, insurance providers, etc.) to better understand the need, and determine what kind of solutions would…

Read More

Specialist Series: Finding and Defining Your Unmet Need

Contributed by Josh Tolkoff The most common reason for the commercial failure of a start-up entity is not having a compelling clinical need.  What exactly is an “unmet need”?  An unmet need is something more than an incremental improvement, and once it exists in the market it will make a substantial change for the better.…

Read More

NEW AWARD: CONGRATULATIONS, DR. SYLVIE BRETON!

RECIPIENT:  Dr. Sylvie Breton TITLE: Predicting and Preventing Acute Kidney Injury Associated with Cardiovascular Diseases TYPE OF AWARD:  PILOT TECHNOLOGY TYPE: Small Molecule Drug CLINICAL AREA: Heart INDICATION: Acute Kidney Injury INSTITUTION: MGH DESCRIPTION:  Acute kidney injury (AKI) is a frequent complication of hospitalized patients. Unfortunately, there is no cure for this potentially deadly condition. Thus, a critical…

Read More